Michael Gaume, MD
Pain Medicine · Topeka, KSNPI 1407804495
Payments from drug & device makers
What this record shows
Medtronic accounts for 77.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $1,378 and has fallen 89.3% since, to $148 in 2024. That places this record below the midpoint for pain medicine clinicians in KS, where the typical reported total is $2,519.
Across 37 payments — averaging $63.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Nevro Corp.$278
- Boston Scientific$201
- Abbott$34
- Avanos Medical$20
What the payments were for
- Travel & lodging$1,02744%
- Food & beverage$1,32056%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 25 | $1,814 |
| Nevro Corp. | 3 | $278 |
| Boston Scientific | 5 | $201 |
| Abbott | 3 | $34 |
| Avanos Medical | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,121
- Omnia$259
- SPECTRA WAVEWRITER$117
How this compares
$2,347 in reported general payments places this provider in the 45th percentile of 64 pain medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 113 | $863 |
| Duloxetine Hcl | 71 | $597 |
| Lidocaine | 12 | $592 |
| Methylprednisolone | 65 | $452 |
| Tizanidine Hcl | 67 | $377 |
| Tramadol Hcl | 25 | $203 |
| Meloxicam | 55 | $134 |
| Cyclobenzaprine Hcl | 15 | $132 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Topeka
- Brant SmithTopeka$150
- Florin NicolaeTopeka$88
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Mayank GuptaOverland Park$199K
- Brian GoentzelWichita$99K
- Brian KimOverland Park$61K
- Jeffrey FosterOverland Park$56K
- Smith ManionShawnee Mission$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.